lormetazepam has been researched along with physostigmine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Doenicke, A; Fichte, K; Grote, B; Kugler, J; Laub, M; Ott, H; Suttmann, H; Zwisler, P | 1 |
2 other study(ies) available for lormetazepam and physostigmine
| Article | Year |
|---|---|
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
[The antagonistic effect of physostigmine on sedation by lormetazepam (author's transl)].
Topics: Anti-Anxiety Agents; Arousal; Benzodiazepines; Electroencephalography; Humans; Lorazepam; Male; Physostigmine; Sleep Stages; Statistics as Topic; Time Factors | 1981 |